As of 2026-04-03, the Relative Valuation of Antibe Therapeutics Inc (ATE.TO) is (1.24) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.30 CAD, the upside of Antibe Therapeutics Inc based on Relative Valuation is -520.7%.
The range of the Relative Valuation is (1.02) - (3.88) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.7x - 11.0x | 3.4x |
| Forward P/E multiples | 2.9x - 10.9x | 3.6x |
| Fair Price | (1.02) - (3.88) | (1.24) |
| Upside | -446.2% - -1415.0% | -520.7% |
| Date | P/E |